205-4475 Wayburne Drive
Member Sector: Biopharmaceuticals
Symvivo Incorporated is a privately held biotechnology company committed to developing therapeutics to effectively treat diseases of the human gastrointestinal tract. Symvivo has developed a proprietary biological-based molecular delivery system that provides the ability to target tissues in a therapeutically relevant and selective fashion. Symvivo is currently focused on building its core technology through in-house research programs and applying it to advance its preclinical pipeline. Symvivo is located in Vancouver, BC.